Mitochondria are the body's "energy factories," and their proper function is essential for life. Inside mitochondria, a set of complexes called the oxidative phosphorylation (OxPhos) system acts like ...
Primary hepatocellular carcinoma (HCC), the major type of liver cancer, is a leading cause of worldwide cancer-related death. End-stage liver cancer patients have limited treatment options due to the ...
Mitochondria are known as the body’s “energy factories,” and their function is essential for life. Inside mitochondria, a set of complexes called the oxidative phosphorylation (OxPhos) system ...
Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid tumors. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a ...
Mitochondria are the body's "energy factories," and their proper function is essential for life. Inside mitochondria, a set of complexes called the oxidative phosphorylation (OxPhos) system acts like ...
A research team led by CiRA Professor Junya Toguchida in collaboration with Assistant Professor Yonghui Jin and graduated student Liping Sun at the Institute for Life and Medical Sciences, Kyoto ...
Combination therapy with FDA-approved oxidative phosphorylation (OXPHOS) inhibitors and platelet-derived growth factor receptor (PDGFR) inhibitors may selectively target ovarian cancer stem cells and ...
Immunomet Therapeutics Inc.’s chief scientific officer, Sanghee Yoo, told BioWorld Today that $5.2 million in series A money will take the company to the start of phase I trials with oxidative ...
Figure 1 BET inhibition is synthetic lethal to OXPHOS blockage in liver cancer. Left: GDH1-dependent glutamine metabolic remodeling upon BET inhibition. Right: “Synthetic lethality” targeting OXPHOS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results